Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record for the nivolumab and metformin study in treatment-refractory MSS colorectal cancer is displayed, including study details, participation criteria, outcomes, collaborators, and supporting documents.SummaryDifference56%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAn NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe displayed site revision changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study content and documents with an access-denied message. This indicates restricted access to the study record on ClinicalTrials.gov.SummaryDifference19%

- Check58 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, reflecting a newer version of the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor backend/template update that does not change visible content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.